Cleared Traditional

K021986 - BRAINET

K021986 is an FDA 510(k) clearance for BRAINET, manufactured by Nicolet Biomedical, Inc.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 66-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2002
Decision
66d
Days
Class 2
Risk

K021986 is an FDA 510(k) clearance for the BRAINET. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Nicolet Biomedical, Inc. (Stoughton, US). The FDA issued a Cleared decision on August 23, 2002 after a review of 66 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nicolet Biomedical, Inc. devices

FDA 510(k) Submission Details - K021986

510(k) Number K021986 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 18, 2002
Decision Date August 23, 2002
Days to Decision 66 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
83d faster than avg
Panel avg: 149d · This submission: 66d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 337
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K021986.
MULTIPURPOSE NEUROPLUS ELECTRODE, MODEL A10005
K021537 · Vermont Medical, Inc. · Mar 2003
MODEL 4310 PSARRAY2 EEG ELECTRODE
K020670 · Physiometrix, Inc. · Oct 2002
DOCXS B SERIES ELECTRODES
K020903 · Docxs, LLC · Sep 2002
SOF-PACH REUSABLE NEUROSTIMULATION ELECTRODES
K020735 · Cathay International, Ltd. · Jul 2002
THE ELECTRODE STORE SURFACE (CUTANEOUS) ELECTRODE FOR EMG
K020445 · The Electrode Store, Inc. · May 2002
LYMPHA VISION-EXPERT
K003896 · Bexley Trading, Inc. · Apr 2002